Cargando…

Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause

OBJECTIVE: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaeger, Marianna de B., Miná, Camila S., Alves, Sofia, Schuh, Gabriela J., Wender, Maria C., Manfro, Gisele G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136388/
https://www.ncbi.nlm.nih.gov/pubmed/33053044
http://dx.doi.org/10.1590/1516-4446-2020-0871
_version_ 1783695433488400384
author Jaeger, Marianna de B.
Miná, Camila S.
Alves, Sofia
Schuh, Gabriela J.
Wender, Maria C.
Manfro, Gisele G.
author_facet Jaeger, Marianna de B.
Miná, Camila S.
Alves, Sofia
Schuh, Gabriela J.
Wender, Maria C.
Manfro, Gisele G.
author_sort Jaeger, Marianna de B.
collection PubMed
description OBJECTIVE: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect symptoms. METHODS: A cross-sectional study was conducted with 89 perimenopausal women aged 45-55 years. Broad psychiatric and clinical evaluations were carried out. The primary outcome was the vasomotor symptom problem rating and the main study factor was anxiety sensitivity. Linear regression analyses were conducted to examine the associations between the study factors and the primary outcome, and a multiple regression model was created to assess which variables were independently associated with vasomotor symptom problem rating. RESULTS: The prevalence of anxiety, depression, and vasomotor symptoms were 58, 62, and 73%, respectively. Negative affect symptoms were positively associated with vasomotor symptom problem rating. The association of anxiety sensitivity and vasomotor symptom problem rating remained significant after controlling for perimenopausal stage, thyrotropin, follicle-stimulating hormone levels, and psychotropic medication use (β = 0.314, p = 0.002). CONCLUSION: A better understanding of the experience of vasomotor symptoms is needed, especially the role of negative affect symptoms and anxiety sensitivity. New strategies focusing on related thoughts and behaviors could improve the quality of life of perimenopausal women.
format Online
Article
Text
id pubmed-8136388
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Associação Brasileira de Psiquiatria
record_format MEDLINE/PubMed
spelling pubmed-81363882021-05-26 Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause Jaeger, Marianna de B. Miná, Camila S. Alves, Sofia Schuh, Gabriela J. Wender, Maria C. Manfro, Gisele G. Braz J Psychiatry Original Article OBJECTIVE: Vasomotor symptoms affect 60-80% of women during the menopausal transition. Anxiety, depression, and anxiety sensitivity can have an important role in the distressful experience of vasomotor symptoms. Our aim was to evaluate the prevalence and association of vasomotor and negative affect symptoms. METHODS: A cross-sectional study was conducted with 89 perimenopausal women aged 45-55 years. Broad psychiatric and clinical evaluations were carried out. The primary outcome was the vasomotor symptom problem rating and the main study factor was anxiety sensitivity. Linear regression analyses were conducted to examine the associations between the study factors and the primary outcome, and a multiple regression model was created to assess which variables were independently associated with vasomotor symptom problem rating. RESULTS: The prevalence of anxiety, depression, and vasomotor symptoms were 58, 62, and 73%, respectively. Negative affect symptoms were positively associated with vasomotor symptom problem rating. The association of anxiety sensitivity and vasomotor symptom problem rating remained significant after controlling for perimenopausal stage, thyrotropin, follicle-stimulating hormone levels, and psychotropic medication use (β = 0.314, p = 0.002). CONCLUSION: A better understanding of the experience of vasomotor symptoms is needed, especially the role of negative affect symptoms and anxiety sensitivity. New strategies focusing on related thoughts and behaviors could improve the quality of life of perimenopausal women. Associação Brasileira de Psiquiatria 2020-10-09 /pmc/articles/PMC8136388/ /pubmed/33053044 http://dx.doi.org/10.1590/1516-4446-2020-0871 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jaeger, Marianna de B.
Miná, Camila S.
Alves, Sofia
Schuh, Gabriela J.
Wender, Maria C.
Manfro, Gisele G.
Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
title Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
title_full Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
title_fullStr Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
title_full_unstemmed Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
title_short Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
title_sort negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136388/
https://www.ncbi.nlm.nih.gov/pubmed/33053044
http://dx.doi.org/10.1590/1516-4446-2020-0871
work_keys_str_mv AT jaegermariannadeb negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause
AT minacamilas negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause
AT alvessofia negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause
AT schuhgabrielaj negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause
AT wendermariac negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause
AT manfrogiseleg negativeaffectsymptomsanxietysensitivityandvasomotorsymptomsduringperimenopause